EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Vaccarin Improves Myocardial Ischemia–Reperfusion Injury by Attenuating Oxidative Stress and Ferroptosis Through Reducing NOX4 ‐Modulated JAK2 / STAT3 Pathway Activation

Han Yang, Mi Zhou, Feng‐Cai Zhang

The Kaohsiung Journal of Medical Sciences · 2026-11 · 42 (11)

DOI: 10.1002/kjm2.70226 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Vaccarin is a naturally occurring flavonoid glycoside with cardioprotective properties; however, its involvement in myocardial ischemia–reperfusion (MI/R) injury remains poorly defined. We herein investigated whether vaccarin protects cardiomyocytes from MI/R‐induced dysfunction in vivo and in vitro and examined the associated molecular mechanisms. To explore the protective effects of vaccarin, we established an MI/R injury mouse model and in vitro hypoxia/reoxygenation (H/R) injury model using H9c2 cardiomyocytes. In vivo results showed that vaccarin alleviated MI/R injury. In H9c2 cells, vaccarin partially reversed the H/R‐induced elevation of reactive oxygen species and malondialdehyde levels and restored the reduced activity of superoxide dismutase. Vaccarin also suppressed the H/R‐induced accumulation of Fe 2+ and glutathione disulfide while restoring the levels of glutathione, solute carrier family 7 member 11, and glutathione peroxidase 4. NADPH oxidase 4 (NOX4) was subsequently identified as a putative molecular target of vaccarin. Moreover, vaccarin inhibited H/R‐induced activation of the Janus kinase 2 (JAK2)/signal transducer and activator of transcription 3 (STAT3) signaling pathway in cardiomyocytes. NOX4 overexpression counteracted vaccarin‐mediated suppression of JAK2/STAT3 signaling and blocked its antioxidative and antiferroptotic effects in H/R‐treated cardiomyocytes. Collectively, these findings indicate that vaccarin confers cardioprotection against MI/R injury by suppressing oxidative stress and ferroptosis, at least partly through inhibition of NOX4‐driven JAK2/STAT3 signaling. These results suggest that vaccarin may be a promising therapeutic candidate for the treatment of MI/R injury.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →